Natixis Repligen Corp Transaction History

Natixis

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $16.1 Million - $20.9 Million	116,052 New	116,052 $16.4 Million
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $1.06 Million - $1.69 Million	-6,561 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $1.62 Million - $2 Million	6,561 New	6,561 $1.74 Million
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $3.9 Million - $4.89 Million	-21,600 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $3.2 Million - $4.46 Million	21,600 New	21,600 $4.14 Million

477

54.9M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.